federal_register: 97-22701

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
97-22701 Specific Requirements on Content and Format of Labeling for Human Prescription Drugs; Addition of ``Geriatric Use'' Subsection in the Labeling Rule The Food and Drug Administration (FDA) is amending its regulations governing the content and format of labeling for human prescription drug products, including biological products, to include information pertinent to the appropriate use of drugs in the elderly (persons aged 65 years and over) and to facilitate access to this information by establishing a ``Geriatric use'' subsection in the labeling. The final rule is one of several measures FDA has taken in response to the special concerns associated with prescription drug use in elderly patients. FDA believes that improving access to information that is important to the elderly will facilitate the safe and effective use of prescription drugs in older populations. 1997-08-27 1997 8 https://www.federalregister.gov/documents/1997/08/27/97-22701/specific-requirements-on-content-and-format-of-labeling-for-human-prescription-drugs-addition-of https://www.govinfo.gov/content/pkg/FR-1997-08-27/pdf/97-22701.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is amending its regulations governing the content and format of labeling for human prescription drug products, including biological products, to include information pertinent to the appropriate use of drugs in the...

Links from other tables